Entia Biosciences, Inc. Stock Other OTC
Equities
ERGO
US29384E1047
Biotechnology & Medical Research
Financials (USD)
Sales 2015 | 347K | Sales 2016 | 265K | Capitalization | 1.58M |
---|---|---|---|---|---|
Net income 2015 | -2M | Net income 2016 | -1M | EV / Sales 2015 | 8.29 x |
Net Debt 2015 | 255K | Net Debt 2016 | 970K | EV / Sales 2016 | 9.59 x |
P/E ratio 2015 |
-0.97
x | P/E ratio 2016 |
-1.13
x | Employees | - |
Yield 2015 * |
-
| Yield 2016 |
-
| Free-Float | 99.44% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 67 | 15-09-30 |
1st Jan change | Capi. | |
---|---|---|
+4.09% | 43.84B | |
+47.41% | 41.25B | |
+9.45% | 41.68B | |
-10.92% | 27.04B | |
+9.32% | 25.53B | |
-24.87% | 18.18B | |
+29.70% | 12.29B | |
+1.28% | 12.29B | |
+7.78% | 11.15B |